Safety Concerns with Valerian Root and Antiepileptic Drugs

Critical Safety Concerns in Epilepsy Patients

The American Society of Anesthesiologists recommends discontinuing valerian at least 2 weeks before surgery due to its sedative properties and potential for additive CNS depression, which is concerning when combined with other CNS-active medications like antiepileptic drugs 1
When combined with other CNS-active medications, valerian may potentiate sedation and cognitive impairment, as both Keppra and Dilantin can cause sedation, dizziness, and cognitive effects 1, 2

The American Academy of Sleep Medicine explicitly recommends against using valerian for sleep onset or sleep maintenance insomnia, with a weak recommendation 3, 4, 5, 6
The risk-benefit ratio is unfavorable, with potential drug interactions and seizure destabilization versus no proven therapeutic benefit 3

Cognitive Behavioral Therapy for Insomnia (CBT-I) should be the first-line treatment before consideringogle considering any medications or supplements 7
If pharmacotherapy becomes necessary, low-dose doxepin (3-6mg) is most appropriate for sleep maintenance insomnia with a favorable safety profile 7
Ramelteon 8mg may be considered for sleep onset insomnia 7
Sleep hygiene education and stimulus control therapy are evidence-based non-pharmacological interventions 7
The American Psychiatric Association notes that standard treatments for anxiety disorders have better-established efficacy and safety data 1
Evidence-based psychotherapy and FDA-approved medications have more robust safety profiles than herbal supplements in patients with epilepsy 1